A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
出版年份 2011 全文链接
标题
A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 85, Issue 20, Pages 10572-10581
出版商
American Society for Microbiology
发表日期
2011-08-18
DOI
10.1128/jvi.05541-11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity
- (2010) Joshua S Klein et al. AIDS
- Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances
- (2010) Irene A. Abela et al. CURRENT PHARMACEUTICAL DESIGN
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Fc-Glycosylation Influences Fc Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
- (2010) D. N. Forthal et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Replication in Langerhans and Interstitial Dendritic Cells Is Inhibited by Neutralizing and Fc-Mediated Inhibitory Antibodies
- (2010) M. Peressin et al. JOURNAL OF VIROLOGY
- In-Solution Virus Capture Assay Helps Deconstruct Heterogeneous Antibody Recognition of Human Immunodeficiency Virus Type 1
- (2010) D. P. Leaman et al. JOURNAL OF VIROLOGY
- Antibodies to watch in 2010
- (2010) Janice M. Reichert mAbs
- CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
- (2009) F. T. Awan et al. BLOOD
- A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
- (2009) Pina M. Cardarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41
- (2009) L. G. Perez et al. JOURNAL OF VIROLOGY
- Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
- (2009) Ann J Hessell et al. NATURE MEDICINE
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fc receptor-mediated antiviral antibodies
- (2009) Donald N Forthal et al. Current Opinion in HIV and AIDS
- The Cat and Mouse of HIV-1 Antibody Escape
- (2009) John R. Mascola PLoS Pathogens
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now